Volume 28, Number 12—December 2022
Research
Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1
Table 4
Sample | Method | Limit of detection | AUC | Slope |
---|---|---|---|---|
AHSV-1 Thailand 110983/63 |
AHSV VP7 rRT-PCR | [10−5] | 0.943 |
−3.89 |
AHSV-1 VP2 Serotyping rRT-PCR | [10−4] | |||
AHSV-1 VP5 DIVA rRT-PCR 1 |
[10−4] |
|||
AHSV-1 OBP LAV | AHSV VP7 rRT-PCR | [10−6] | 0.900 | −3.49 |
AHSV-1 VP2 Serotyping rRT-PCR | [10−5] | |||
AHSV-1 VP5 DIVA rRT-PCR 2 | [10−5] |
*The limit of detection was reported from the lowest observed amount of DNA amplified below the Ct <40 threshold. The AUC and slope values derived from the calibration curve are also listed. AHSV, African horse sickness virus; AUC, area under the receiver operating curve; Ct, cycle threshold; DIVA, Differentiating Infected from Vaccinated Animals; OBP LAV, Onderstepoort Biologic Products (https://www.obpvaccines.co.za) live attenuated vaccine; rRT-PCR, real-time reverse transcription PCR; VP, viral protein.
Page created: October 28, 2022
Page updated: November 21, 2022
Page reviewed: November 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.